- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03792022
Timeliness and Completeness of Routine Childhood Vaccinations by 2 Years of Age in Nigeria.
December 31, 2018 updated by: Dr.Ihedioha Emmanuel Chukwunwike, Lifespan Healthcare Resource Limited
Fully Vaccinated Yet Under-vaccinated: Timeliness and Completeness of Routine Childhood Vaccinations by 2 Years of Age in Nigeria
The timeliness of routine childhood immunization should be an important component in measuring vaccination coverage rates especially in LMIC countries like Nigeria, yet this is overlooked.
This study will determine the age- specific immunization timely uptake rates for the various vaccines covered in the routine childhood immunization and seek out factors that affect timely vaccine uptake among Nigerian children.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This study will determine the extent of timely and complete routine childhood vaccination uptake in Nigeria.
The investigators will also seek to understand the factors that influence timely/complete uptake and make recommendations.
this study will also determine if the present immunization records system in Nigeria is capable of measuring timely immunization uptake.
Study Type
Observational
Enrollment (Anticipated)
1800
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 2 years (CHILD)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Vaccination records of children who have attended immunization clinics for the last 24 months.
Description
Inclusion Criteria:
- Received all vaccines Available immunization records
Exclusion Criteria:
- Did not receive all vaccines Non- available immunization records
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
Adherence to timely vaccine uptake
|
Adherence to timely vaccine uptake
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age specific timely vaccination rate for all vaccines in routine vaccination schedule
Time Frame: 24 months
|
The primary outcome measure, age- appropriate immunization is defined as receipt of a scheduled vaccine dose within 30 days of the recommended age.
Timeliness will be calculated using child health card data as at 31st December 2018.
Descriptive statistics will be produced to describe the characteristics of the sample using frequencies and proportions.
Descriptive outcome measures for each dose will be coded as either 'no delay'- age appropriately immunized, delay of 1-6 months' , 'delay greater than 6 months', vaccine received 'acceptably early' (within 30 days prior to when it was due), vaccines received 'too early' (within 30 days prior to when it was due) or vaccine dose not recorded.
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
January 10, 2019
Primary Completion (ANTICIPATED)
March 31, 2019
Study Completion (ANTICIPATED)
April 2, 2019
Study Registration Dates
First Submitted
December 29, 2018
First Submitted That Met QC Criteria
December 31, 2018
First Posted (ACTUAL)
January 3, 2019
Study Record Updates
Last Update Posted (ACTUAL)
January 3, 2019
Last Update Submitted That Met QC Criteria
December 31, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 002 (University of CT Health Center)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccination Failure
-
Centre Hospitalier Universitaire de NiceCompletedVaccination Failure
-
University of Roma La SapienzaCompletedVaccination Failure | Vaccination Adverse Events | Specific Antibody ResponseItaly
-
Aga Khan UniversityWorld Health OrganizationUnknownVaccination FailurePakistan
-
Aga Khan UniversityWorld Health OrganizationUnknown
-
University of AlbertaMerck Canada Inc.Not yet recruitingVaccine Response Impaired | Vaccination Failure
-
University of PennsylvaniaCompletedVaccine Refusal | Vaccination Hesitancy | Human Papillomavirus VaccinationUnited States
-
National Cancer Institute (NCI)CompletedHPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post VaccinationUganda
-
Indiana UniversityNational Center for Advancing Translational Sciences (NCATS)Recruiting
-
Columbia UniversitySeattle Children's Hospital; New York Presbyterian Hospital; Agency for Healthcare...Completed
-
China National Biotec Group Company LimitedBeijing Institute of Biological Products Co Ltd.; Wuhan Institute of Biological... and other collaboratorsUnknown
Clinical Trials on Adherence to timely vaccine uptake
-
Northwestern UniversityNot yet recruitingAcute Lymphoblastic Leukemia
-
RANDNational Institute of Mental Health (NIMH); Arizona State University; Mildmay...Active, not recruiting
-
University of VirginiaVirginia Department of HealthCompletedPrEP | HIV Prevention | Adherence, MedicationUnited States
-
RANDMildmay Uganda LimitedCompleted
-
Cedarville UniversityMerck Investigator Studies Program; Rocking Horse Community Health CenterCompletedVaccine HesitancyUnited States
-
RTI InternationalPatient-Centered Outcomes Research Institute; University of California Integrated...CompletedSubstance Use DisordersUnited States
-
RANDNational Institute of Mental Health (NIMH); Mildmay Uganda LimitedCompleted
-
Orion Corporation, Orion PharmaRecruiting
-
Istanbul Demiroglu Bilim UniversityTurkish Society of Clinical Enteral and Parenteral NutritionCompletedMicrobial Colonization | Enteral Nutrition | AdherenceTurkey
-
Rhode Island HospitalWithdrawnMedication Adherence | Telemedicine | Pre-Exposure ProphylaxisUnited States